| abstract |
Disclosed is a therapeutic agent for normalizing abnormal lipid metabolism. A known protein derived from human fibroblasts, TCF-II (amino acid number: 723, molecular weight of 78,000 ± 2,000 or 74,000 ± 2,000 under non-reduction) as an active ingredient A therapeutic agent for abnormal lipid metabolism. [Effect] It has a lecithin-cholesterol acyltransferase (LCAT) activity increasing effect and a therapeutic effect on hypertriacylglycerolemia caused by cholestasis. [Selection figure] None |